	US 11,857,642 B2
	SYNP161, a promoter for the expression of genes
Dominik Hartl, Birsfelden (CH); Josephine Juettner, Basel (CH); Arnaud Krebs, Habsheim (FR); Botond Roska, Oberwil (CH); and Dirk Schuebeler, Basel (CH)
Assigned to Friedrich Miescher Institute for Biomedical Research, Basel (CH)
Filed by Friedrich Miescher Institute for Biomedical Research, Basel (CH)
Filed on Jan. 22, 2021, as Appl. No. 17/155,743.
Application 17/155,743 is a continuation of application No. 15/780,567, granted, now 10,898,586, previously published as PCT/IB2016/057267, filed on Dec. 1, 2016.
Claims priority of application No. 15197901 (EP), filed on Dec. 3, 2015.
Prior Publication US 2021/0213143 A1, Jul. 15, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 48/00 (2006.01); C12N 15/86 (2006.01); C12N 15/63 (2006.01); C12N 15/79 (2006.01)

CPC A61K 48/0058 (2013.01) [A61K 48/00 (2013.01); C12N 15/63 (2013.01); C12N 15/79 (2013.01); C12N 15/86 (2013.01); C12N 2750/14143 (2013.01); C12N 2830/008 (2013.01)]

18 Claims

1. An expression cassette comprising:

an isolated nucleic acid molecule comprising a nucleic acid sequence of at least 150 base pairs and having at least 95% identity to the sequence of SEQ ID NO:1; and

a nucleic acid sequence encoding for a gene,

wherein said isolated nucleic acid molecule is effective to drive expression of the gene in cells, and wherein the nucleic acid sequence coding for said gene is operatively linked to said isolated nucleic acid molecule.